| For: | Maity R, Dhali A, Biswas J. Is Helicobacter pylori infection protective against esophageal cancer? World J Gastroenterol 2024; 30(38): 4168-4174 [PMID: 39493327 DOI: 10.3748/wjg.v30.i38.4168] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i38/4168.htm |
| Number | Citing Articles |
| 1 |
He Xin, Chi Zhu, Chan Zhu, Xing Zhang, Dongsheng Chen, Qingping Wang. Beyond the stomach: the association between Helicobacter pylori and the spectrum of digestive cancers. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1633227
|
| 2 |
Ahan Bhatt, Hasan Musanna Zaidi, Radhashree Maitra, Sanjay Goel. Infectious Agents and Esophageal Cancer: A Comprehensive Review. Cancers 2025; 17(7): 1248 doi: 10.3390/cancers17071248
|
| 3 |
Vinit H. Majmudar, Kyle Nguyen-Ngo, Michael Tadros. Divergent Trends in Esophageal Adenocarcinoma and Squamous Cell Carcinoma Incidence, 2000–2022. Gastroenterology Insights 2025; 16(4): 37 doi: 10.3390/gastroent16040037
|
| 4 |
Jingping Hu, Lintao Dong, Fang Wang. Use of bidirectional Mendelian randomization to unveil the association of Helicobacter pylori infection and pancreatic cancer. Medicine 2025; 104(39): e44585 doi: 10.1097/MD.0000000000044585
|
| 5 |
Dan Ren, Manli Cui, Duo Yang, Yu Zhang, Yuanzhu Hao, Yixing Yue, Bin Wei, QingLing Fan, Chao Sun, Qian Li, Mingxin Zhang.
Helicobacter pylori
in esophageal carcinogenesis: Potential culprit or forceful defender?
. Virulence 2025; 16(1) doi: 10.1080/21505594.2025.2580749
|
| 6 |
Liza Eiman, Khadija Moazzam, Sumaira Anjum, Humera Kausar, Elham Abdullatif M. Sharif, Wisam Nabeel Ibrahim. Gut dysbiosis in cancer immunotherapy: microbiota-mediated resistance and emerging treatments. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1575452
|
